Target intelligence / Profile preview

Innate killer cell immunological synapse (IKC-IS)

Target
IKC-IS
Molecular classification
Other, Receptor
01

Overview

The innate killer cell (IKC) immunological synapse is a specialized, highly organized supramolecular activation cluster (SMAC) formed at the interface between an innate killer cell—such as a Natural Killer (NK) cell, Natural Killer T (NKT) cell, or γδ T cell—and a target cell, typically a malignant or virus-infected cell [1, 10]. This synapse is characterized by the dynamic rearrangement of the actin cytoskeleton and the clustering of activating receptors (e.g., NKG2D, CD16, NKp46) and adhesion molecules (e.g., LFA-1) at the central and peripheral zones [10]. The formation of a stable synapse is essential for the polarized secretion of lytic granules containing perforin and granzymes, which induce apoptosis in the target cell [1, 10]. In therapeutic contexts, this synapse is the primary target of bispecific killer engagers (BiKEs), trispecific killer engagers (TriKEs), and chimeric antigen receptor (CAR)-engineered IKCs, which are designed to bypass inhibitory signals and force the assembly of a functional lytic interface [1, 9]. Dysregulation or failure to form an effective synapse is a key mechanism of immune evasion in cancer and chronic viral infections [7].

Other names
NK cell immunological synapseInnate killer cell synapseLytic synapseNK-cell synapseImmune killer cell immunological synapseInduced killer cell immunological synapseIKC-IS
02

Mechanism of action

Induction of lytic granule exocytosis and target cell apoptosis through the coordinated clustering of activating receptors and the exclusion of inhibitory signals at the cellular interface.

03

Biological functions

Immune responseCell deathSignal transductionApoptosisCellular adhesionExocytosis
04

Disease associations

CancerInfectionImmunodeficiency
05

Safety considerations

Cytokine release syndrome (CRS)Off-target toxicity against healthy tissuesTumor escape via antigen or ligand sheddingImpaired synapse formation due to genetic cytoskeletal defects
06

Interacting drugs

CAR-NK cells (e.g., TAK-007)

4 more in the full profile.

07

Biomarkers

CD107a (LAMP-1) surface expressionPerforin levelsGranzyme B levelsF-actin accumulation at the interfaceMICA/B expression on target cells

Beyond the preview

Go deeper on Innate killer cell immunological synapse (IKC-IS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate killer cell immunological synapse (IKC-IS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call